[HTML][HTML] Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review

S Vygen-Bonnet, W Hellenbrand, E Garbe… - BMC infectious …, 2020 - Springer
Background Infants< 3 months of age are at highest risk for developing severe complications
after pertussis. The majority of pregnant women has low concentrations of pertussis-specific …

[HTML][HTML] COVID-19 vaccination in pregnancy and lactation: current research and gaps in understanding

LL Shook, PN Fallah, JN Silberman… - Frontiers in cellular and …, 2021 - frontiersin.org
The COVID-19 pandemic has demonstrated the urgent need to develop vaccine strategies
optimized for pregnant people and their newborns, as both populations are at risk of …

[HTML][HTML] Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms

CG Atyeo, LL Shook, S Brigida, RM De Guzman… - Nature …, 2022 - nature.com
The availability of three COVID-19 vaccines in the United States provides an unprecedented
opportunity to examine how vaccine platforms and timing of vaccination in pregnancy impact …

[HTML][HTML] Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study

M Sadarangani, P Soe, HP Shulha… - The Lancet Infectious …, 2022 - thelancet.com
Background Pregnant individuals have been receiving COVID-19 vaccines following pre-
authorisation clinical trials in non-pregnant people. This study aimed to determine the …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

[HTML][HTML] Immunological and clinical benefits of maternal immunization against pertussis: a systematic review

C Switzer, C D'Heilly, D Macina - Infectious Diseases and Therapy, 2019 - Springer
Infants are vulnerable to pertussis infection particularly before initiation of pertussis
vaccination. Maternal pertussis vaccination during pregnancy has been introduced in a …

Non‐Viral RNA Delivery During Pregnancy: Opportunities and Challenges

N Chaudhary, AN Newby, KA Whitehead - Small, 2023 - Wiley Online Library
During pregnancy, the risk of maternal and fetal adversities increases due to physiological
changes, genetic predispositions, environmental factors, and infections. Unfortunately …

[HTML][HTML] Safety of maternal immunization against pertussis: a systematic review

C D'Heilly, C Switzer, D Macina - Infectious diseases and therapy, 2019 - Springer
The WHO recommends vaccination of all children against pertussis. However, newborn
infants remain vulnerable to infection. Pertussis vaccination during pregnancy has been …

Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons

M Prabhu, YJ Yang, CD Johnston, EA Murphy… - American Journal of …, 2023 - Elsevier
BACKGROUND For some vaccine-preventable diseases, the immunologic response to
vaccination is altered by a pregnant state. The effect of pregnancy on SARS-CoV-2 vaccine …

[HTML][HTML] Vaccination in pregnancy

M Röbl-Mathieu, A Kunstein, J Liese… - Deutsches Ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Vaccination during pregnancy can protect both the expecting mother and the
unborn and newborn child from infectious diseases. Methods This review is based on …